For media requests, please contact press@dnastack.com.
Download Press KitThe purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
The purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
The purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
The purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
The purpose of this study was to develop a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
Almost sixty percent of the human population resides in Asia and Africa, but only a fraction of the world’s human genomic sequencing efforts cover that community.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon Project that will improve the discoverability of European genomic data.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
Members of the International Canadian Data Sharing Initiative (Can-SHARE) have announced the recipients of C$700,000 ($522,000) in funding under their New Initiatives program.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
This week DNAstack, a Toronto-based genomic software company, launched its Google Cloud platform to accelerate genetic disease research and precision medicine.
Genomics software startup DNAstack this week unveiled its first product, a cloud-based platform that provides tools to help genetics researchers share and analyze biomedical data in the Google cloud.
Genomics software startup DNAstack this week unveiled its first product, a cloud-based platform that provides tools to help genetics researchers share and analyze biomedical data in the Google cloud.
Genomics software startup DNAstack this week unveiled its first product, a cloud-based platform that provides tools to help genetics researchers share and analyze biomedical data in the Google cloud.
Genomics software startup DNAstack this week unveiled its first product, a cloud-based platform that provides tools to help genetics researchers share and analyze biomedical data in the Google cloud.
Genomics software startup DNAstack this week unveiled its first product, a cloud-based platform that provides tools to help genetics researchers share and analyze biomedical data in the Google cloud.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
Early data-sharing efforts have led to improved variant interpretation and development of treatments for rare diseases and some cancer types.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
In today’s Science, the Global Alliance for Genomics and Health (GA4GH) calls for a federated data ecosystem for sharing genomic and clinical data.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
JLABS will let startups in therapeutic, pharmaceutical, medical device and consumer health research test out ideas with access to state-of-the-art equipment, without giving up equity.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
Genome Canada and the Canadian Institutes of Health Research (CIHR) today announced a $3.3 million investment in Can-SHARE – a pan-Canadian program that will enable innovation in the use of genomic data for health care for patients in Canada and worldwide.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
The Can-Share program seeks to build policies and data tools to share data among Canadian research institutions and with international partners.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
Through its Data Working Group, GA4GH wants to replace many existing standards, conventions, and file formats with new ones that will scale to searching through genomes at the level of whole populations ― and, crucially, make it easier for separate organizations to share data.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
The DNAstack platform is built on Google Genomics and Google Cloud Platform, giving researchers fast, easy, and more secure access to genomics data for analysis and sharing.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
In February MIT Technology Review chose their 10 Breakthrough Technologies of 2015—here’s how they have advanced since.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
A coalition of geneticists and computer programmers calling itself the Global Alliance for Genomics and Health is developing protocols for exchanging DNA information across the Internet.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.
Research labs across Ontario are full of ingenious – and even life-saving – inventions.